Journal
MEDICAL ENGINEERING & PHYSICS
Volume 26, Issue 4, Pages 279-290Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.medengphy.2004.01.006
Keywords
electromyography; Parkinson's disease; medication; wavelets
Categories
Ask authors/readers for more resources
The improvements in the motor ability in patients with Parkinson's disease due to antiparkinsonian medication is well-known and widely documented. Recent results, based both on kinematic parameters and standard electromyographic (EMG) signal analysis. clearly indicated that the medication reduced, as expected, the clinical signs of Parkinson's disease, but did not restore agonist burst duration modulation with distance in elbow flexion movements. The main aim of the present work is to shed more light on this medication effect using a wavelet analysis approach on multiple EMG signals recorded both on shoulder and elbow muscles in ballistic or rapid movements. The wavelet cross-correlation information allows Lis to evidence some important quantitative features of the EMG signals due to medication. (C) 2004 IPEM. Published by Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available